Clinical Trial Update: Colchicine in Coronary Artery Bypass Graft (CABG) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating colchicine in patients undergoing elective coronary artery bypass graft surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: G.Gennimatas General Hospital | Conditions: Elective Coronary Artery Bypass Graft Surgery | Phase 4 | Status: COMPLETED